Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bortul

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of General Virology|March 24, 2012
Production of in vivo-biotinylated rotavirus particlesG De Lorenzo, C Eichwald, E M Schraner, et al.
Journal of Cellular Biochemistry. Supplement|July 17, 2001
Nuclear changes in necrotic HL-60 cellsR Bortul, M Zweyer, A M Billi, et al.
Histology and Histopathology|September 2, 2005
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transductionA M Martelli, R Fiume, I Faenza, et al.
Journal of Cellular Biochemistry|June 8, 2000
Behavior of nucleolar proteins during the course of apoptosis in camptothecin-treated HL60 cellsA M Martelli, I Robuffo, R Bortul, et al.
Journal of Cellular Biochemistry|May 13, 1999
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrixL M Neri, R Bortul, M Zweyer, et al.
Cancer Research|March 8, 2000
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor IA M Martelli, G Tabellini, R Bortul, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
Leukemia|March 16, 2007
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretionP L Tazzari, G Tabellini, R Bortul, et al.
Leukemia|August 22, 2003
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expressionA Cappellini, G Tabellini, M Zweyer, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of General Virology|March 24, 2012
Production of in vivo-biotinylated rotavirus particlesG De Lorenzo, C Eichwald, E M Schraner, et al.
Journal of Cellular Biochemistry. Supplement|July 17, 2001
Nuclear changes in necrotic HL-60 cellsR Bortul, M Zweyer, A M Billi, et al.
Histology and Histopathology|September 2, 2005
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transductionA M Martelli, R Fiume, I Faenza, et al.
Journal of Cellular Biochemistry|June 8, 2000
Behavior of nucleolar proteins during the course of apoptosis in camptothecin-treated HL60 cellsA M Martelli, I Robuffo, R Bortul, et al.
Journal of Cellular Biochemistry|May 13, 1999
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrixL M Neri, R Bortul, M Zweyer, et al.
Cancer Research|March 8, 2000
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor IA M Martelli, G Tabellini, R Bortul, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
Leukemia|March 16, 2007
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretionP L Tazzari, G Tabellini, R Bortul, et al.
Leukemia|August 22, 2003
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expressionA Cappellini, G Tabellini, M Zweyer, et al.
Pageof 4